Skip to main content

Table 3 Summary of all GBS AMSAN variant features after COVID-19 exposure

From: Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report

Patient

Age

Sex

Comorbidity

GBS diagnosis

Additional

Instrumental

Diagnosis

Intercourse between COVID-19 infection and GBS symptoms (days)

IVIG administration

Outcome

G.A.C.

90

F

Hypertension

Clinical, CSF, EMG

none

30

Yes

Death

 

Assini et al. [18]

60

M

None

Clinical, CSF, EMG

Antibody antiganglioside;

SARS-CoV-2 in CSF

20

Yes

Persistent hyporeflexia; slight improvement in right foot drop

 

El Otmani [19]

70

F

Rheumatoid

Arthritis

Clinical, CSF, EMG

SARS-CoV-2 in CSF

3

Yes

No neurological improvement

 

Mozhdehipanah [20]

55

F

COPD

Clinical, CSF, EMG

None

26

Yes

Death for ARDS after third day of IVG

 

Padroni et al. [21]

70

F

None

Clinical, CSF, EMG

None

23

Yes

Unknown

 

Sedaghat et al. [22]

65

M

Diabetes mellitus

Clinical, CSF, EMG

Cerebral and spinal MRI

14

Yes

Unknown

 

Toscano et al. [23]

77

F

hypertension, stroke, atrial fibrillation

Clinical, CSF, EMG

Antibody antiganglioside;

SARS-CoV-2 in CSF; Cerebral and spinal MRI

7

Yes

No neurological improvement

 

Toscano et al. [23]

23

M

None

Clinical, CSF, EMG

Antibody antiganglioside;

SARS-CoV-2 in CSF; Cerebral and spinal MRI

10

Yes

Neurological improvement of ataxia and facial weakness

 
  1. Abbreviations: CSF cerebrospinal fluid, EMG electromyography, MRI magnetic resonance imaging, CODP chronic obstructive pulmonary disease